A new study identifies potential immune profile differences in patients with chronic lymphocytic leukemia (CLL) that may lead to resistance after ibrutinib therapy. Researchers analyzed peripheral ...
Ibrutinib normalizes RBC aggregation in CLL, potentially reducing thrombotic risks by mitigating blood flow complications. Obinutuzumab/venetoclax combination does ...
SurvivorNet on MSN
Understanding BTK inhibitors: Uses and limitations in CLL treatment
For many people, BTK inhibitors control CLL for years. They are taken as pills and, in most cases, are continued for as long ...
Verywell Health on MSN
How is chronic lymphocytic leukemia (CLL) treated?
Medically reviewed by Archana Sharma, DO Key Takeaways Active surveillance, or watchful waiting, is often recommended for ...
B-cell chronic lymphocytic leukemia (CLL) occurs when abnormal B cells accumulate in the bone marrow and blood. This crowds out healthy blood cells and weakens the body’s ability to fight infections.
Jim Plotkin shares his personal experience with CLL, including his initial symptoms, the diagnostic process, challenges faced, and advice for patients with newly diagnosed CLL. Medical experts discuss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results